| GRIVELMA Glaxo Group Limited
87453632 17 May 2017 | on 21 Jun 2024 | Pharmaceutical preparations and substances for the treatment of damage... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines | | | QYNAETA Glaxo Group Limited
86902360 09 Feb 2016 | on 28 Jun 2024 | Pharmaceutical preparations and substances for the treatment of damage... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, inflammation, sepsis, alopecia and obesity; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; Vaccines | | | QUYNAETA Glaxo Group Limited
86902351 09 Feb 2016 | on 28 Jun 2024 | Pharmaceutical preparations and substances for the treatment of damage... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, inflammation, sepsis, alopecia and obesity; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; Vaccines | | | TOQUELPA Glaxo Group Limited
86641990 27 May 2015 | on 28 May 2024 | The word(s) "TOQUELPA" has no meaning in a foreign language.,Pharmaceu... Class 005 Class 005 Pharmaceutical Products The word(s) "TOQUELPA" has no meaning in a foreign language. | | | CIMTOPIA Glaxo Group Limited
86635714 20 May 2015 | on 28 May 2024 | Pharmaceutical preparations and substances for the treatment of influe... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the treatment of influenza | | | CIMTOPA Glaxo Group Limited
86635760 20 May 2015 | on 28 May 2024 | Pharmaceutical preparations and substances for the treatment of influe... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the treatment of influenza | | | DEPZEFRA Glaxo Group Limited
97263934 11 Feb 2022 | on 10 Oct 2023 | (Based on Intent to Use) Vaccines; Pharmaceutical preparations and sub... Class 005 Class 005 Pharmaceutical Products (Based on Intent to Use) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders(Based on 44(d) Priority Application) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | DEPVELIA Glaxo Group Limited
97263886 11 Feb 2022 | on 10 Oct 2023 | (Based on Intent to Use) Vaccines; Pharmaceutical preparations and sub... Class 005 Class 005 Pharmaceutical Products (Based on Intent to Use) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders(Based on 44(d) Priority Application) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | KENSTAA Glaxo Group Limited
97169448 13 Dec 2021 | on 17 Jul 2023 | Vaccines; Pharmaceutical preparations and substances for the treatment... Class 005 Class 005 Pharmaceutical Products Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | LUAXTRA Glaxo Group Limited
97169466 13 Dec 2021 | on 17 Jul 2023 | Vaccines; Pharmaceutical preparations and substances for the treatment... Class 005 Class 005 Pharmaceutical Products Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | 
